GEN-009 adjuvanted vaccine

· Genocea Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN-009 adjuvanted vaccine, covering 2022-04-19 to 2022-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine [Phase 1, Phase 2]